-
Je něco špatně v tomto záznamu ?
For Debate: The Significance of Etiologic Diagnosis in Neonates with Overgrowth Syndromes. Lesson Learned from the Simpson-Golabi-Behmel Syndrome
L. Plachý, L. Elblová, V. Neuman, F. Fencl, K. Bláhová, Z. Straňák, J. Lebl, Š. Průhová,
Jazyk angličtina Země Izrael
Typ dokumentu úvodníky
Grantová podpora
NV16-31211A
MZ0
CEP - Centrální evidence projektů
- MeSH
- genetické nemoci vázané na chromozom X * MeSH
- gigantismus * MeSH
- glypikany MeSH
- lidé MeSH
- mentální retardace MeSH
- novorozenec MeSH
- srdeční arytmie MeSH
- vrozené srdeční vady MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- novorozenec MeSH
- Publikační typ
- úvodníky MeSH
Overgrowth syndromes are rare genetic disorders characterized by excessive pre- and postnatal growth accompanied by dysmorphic features and developmental disorders. In addition to other health hazards, the life expectancy of affected children may be compromised due to an increased risk of developing tumors. To demonstrate the need for early recognition, correct diagnostic evaluation and adequate follow-up, we present a family with recurrent Simpson-Golabi-Behmel syndrome (SGBS). SGBS is a X-linked neonatal overgrowth syndrome caused by mutations in the GPC3 or GPC4 genes. All three affected males manifested with congenital diaphragmatic hernia. When fetal overgrowth and congenital diaphragmatic hernia co-occur, the choice for a possible cause is limited among SGBS, Marfan syndrome and Pallister-Killian syndrome. Their different phenotypes allow clinical assessment and correct diagnosis in most cases and should be followed by genetic testing. Regular oncologic screening aimed towards early recognition of malignant tumors may improve long-term outcomes in SGBS as well as in all other overgrowth syndromes.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19028130
- 003
- CZ-PrNML
- 005
- 20190905105735.0
- 007
- ta
- 008
- 190813s2018 is f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.17458/per.vol16.2018.pen.fd.etiologicneonates $2 doi
- 035 __
- $a (PubMed)30371035
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a is
- 100 1_
- $a Plachý, Lukáš $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czech Republic.
- 245 10
- $a For Debate: The Significance of Etiologic Diagnosis in Neonates with Overgrowth Syndromes. Lesson Learned from the Simpson-Golabi-Behmel Syndrome / $c L. Plachý, L. Elblová, V. Neuman, F. Fencl, K. Bláhová, Z. Straňák, J. Lebl, Š. Průhová,
- 520 9_
- $a Overgrowth syndromes are rare genetic disorders characterized by excessive pre- and postnatal growth accompanied by dysmorphic features and developmental disorders. In addition to other health hazards, the life expectancy of affected children may be compromised due to an increased risk of developing tumors. To demonstrate the need for early recognition, correct diagnostic evaluation and adequate follow-up, we present a family with recurrent Simpson-Golabi-Behmel syndrome (SGBS). SGBS is a X-linked neonatal overgrowth syndrome caused by mutations in the GPC3 or GPC4 genes. All three affected males manifested with congenital diaphragmatic hernia. When fetal overgrowth and congenital diaphragmatic hernia co-occur, the choice for a possible cause is limited among SGBS, Marfan syndrome and Pallister-Killian syndrome. Their different phenotypes allow clinical assessment and correct diagnosis in most cases and should be followed by genetic testing. Regular oncologic screening aimed towards early recognition of malignant tumors may improve long-term outcomes in SGBS as well as in all other overgrowth syndromes.
- 650 _2
- $a srdeční arytmie $7 D001145
- 650 12
- $a genetické nemoci vázané na chromozom X $7 D040181
- 650 12
- $a gigantismus $7 D005877
- 650 _2
- $a glypikany $7 D053673
- 650 _2
- $a vrozené srdeční vady $7 D006330
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a novorozenec $7 D007231
- 650 _2
- $a mentální retardace $7 D008607
- 650 _2
- $a mužské pohlaví $7 D008297
- 655 _2
- $a úvodníky $7 D016421
- 700 1_
- $a Elblová, Lenka $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czech Republic.
- 700 1_
- $a Neuman, Vít $7 xx0232676 $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czech Republic.
- 700 1_
- $a Fencl, Filip $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czech Republic.
- 700 1_
- $a Bláhová, Květa $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czech Republic.
- 700 1_
- $a Straňák, Zbyněk $u Department of Neonatology, Institute for the Care of Mother and Child, Prague, Czech Republic.
- 700 1_
- $a Lebl, Jan $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czech Republic, E-mail: Jan.Lebl@Lfmotol.cuni.cz.
- 700 1_
- $a Průhová, Štěpánka $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czech Republic.
- 773 0_
- $w MED00194978 $t Pediatric endocrinology reviews : PER $x 1565-4753 $g Roč. 16, č. 1 (2018), s. 171-177
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30371035 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190813 $b ABA008
- 991 __
- $a 20190905110107 $b ABA008
- 999 __
- $a ok $b bmc $g 1433279 $s 1066590
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 16 $c 1 $d 171-177 $e - $i 1565-4753 $m Pediatric endocrinology reviews $n Pediatr Endocrinol Rev $x MED00194978
- GRA __
- $a NV16-31211A $p MZ0
- LZP __
- $a Pubmed-20190813